WO2016149623A1

WO2016149623A1 - Therapeutic system and method using biphasic or multiphasic pulse waveform

Info

Publication number: WO2016149623A1
Application number: PCT/US2016/023149
Authority: WO
Inventors: Douglas M. RAYMOND; Peter D. Gray
Original assignee: Cardio Thrive, Inc.
Priority date: 2015-03-18
Filing date: 2016-03-18
Publication date: 2016-09-22

Abstract

A therapeutic signal delivery system and method that delivers a dynamically adjustable biphasic or multiphasic pulse are provided. The dynamically adjustable biphasic or multiphasic therapeutic pulse may be used for a variety of therapeutic treatments.

Description

THERAPEUTIC SYSTEM AND METHOD USING BIPHASIC OR MULTIPHASIC PULSE

WAVEFORM

Douglas M. Raymond, Livermore, CA

Peter D. Gray, Vallejo, CA

Priority Claims/Related Applications

This application is a continuation in part of and claims priority under 35 USC 120 to U.S. Patent Application Serial No. 14/303,541, filed on June 12, 2014 and entitled "Dynamically Adjustable Multiphasic Defibrillator Pulse System And Method" which in turn claims priority to under 35 USC 120 and claims the benefit under 35 USC 119(e) of U.S. Provisional Patent Application Serial No. 61/835,443 filed June 14, 2013 and titled "Dynamically Adjustable Multiphasic Defibrillator Pulse System and Method", the entirety of both of which are incorporated herein by reference .

Field

The disclosure relates to medical devices and in particular to devices and methods that generate and deliver therapeutic treatment pulses used in medical devices, such as cardioverters and defibrillators, neuro-stimulators, musculo-skeletal stimulators, organ stimulators and nerve stimulators. More specifically the disclosure relates to the generation and delivery/use by such medical devices of a new and innovatively shaped biphasic or multiphasic pulse waveform. Background

It is well known that a signal having a waveform may have a therapeutic benefit when the signal is applied to a patient. For example, the therapeutic benefit to a patient may be a treatment that is provided to the patient. The therapeutic benefit or therapeutic treatment may include stimulation of a part of the body of the patient or treatment of a sudden cardiac arrest of the patient. Existing systems that apply a signal with a waveform to the patient often generate and apply a well-known signal waveform and do not provide much, or any, adjustability or variability of the signal waveform.

In the context of defibrillators or cardioverters, today's manual defibrillators deliver either an older style Monophasic Pulse (a single high energy single polarity pulse) or the now more common Biphasic Pulse (consisting of an initial positive high energy pulse followed by a smaller inverted negative pulse). Today's implantable cardioverter defibrillators (ICDs), automated external defibrillators (AEDs) and wearable cardioverter defibrillators (WCDs) all deliver Biphasic Pulses with various pulse phase lengths, high initial starting pulse amplitude and various pulse slopes. Each manufacturer of a particular defibrillator, for commercial reasons, has their own unique and slightly different exact timing and shape of the biphasic pulse for their devices' pulses, although they are all based off of the standard biphasic waveform design.

Multiple clinical studies over the last couple of decades have indicated that use of these variants of the biphasic waveform has greater therapeutic value than the older monophasic waveform does to a patient requiring defibrillation therapy and that these standard biphasic waveforms are efficacious at appreciably lower levels of energy delivery than the original monophasic waveforms, and with a higher rate of resuscitation success on first shock delivery.

Thus, almost all of the current defibrillator products that use a biphasic waveform pulse have a single high-energy reservoir, which, while simple and convenient, results in severe limitation on the range of viable pulse shapes that can be delivered. Specifically, the second (or Negative) phase of the Biphasic waveform is currently characterized by a lower amplitude starting point than the first (or Positive) phase of the Biphasic waveform, as shown in Figure 4. This is due to the partial draining of the high-energy reservoir during delivery of the initial Positive phase and then, after inverting the polarity of the waveform so that the Negative phase is able to be delivered, there is only the same partially drained amount of energy remaining in the energy reservoir. This lower amplitude starting point constrains and causes the lower initial amplitude of the Negative phase of the waveform. The typical exponential decay discharge is shown by the Positive phase of the waveform shown in Figure 4.

The standard biphasic pulse waveform has been in common usage in manual

defibrillators and in AEDs since the mid-1990s, and still results in energy levels of anywhere from 120 to 200 joules or more being delivered to the patient in order to be efficacious. This results in a very high level of electrical current passing through the patient for a short period of time which can lead to skin and flesh damage in the form of burns at the site of the electrode pads or paddles in addition to the possibility of damage to organs deeper within the patient's body, including the heart itself. The significant amounts of energy used for each shock and the large number of shocks that these AED devices are designed to be able to deliver over their lifespan, has also limited the ability to further shrink the size of the devices.

WCDs generally need to deliver shocks of 150-200 joules in order to be efficacious, and this creates a lower limit on the size of the electrical components and the batteries required, and hence impacts the overall size of the device and the comfort levels for the patient wearing it.

ICDs, given that they are implanted within the body of patients, have to be able to last for as many years as possible before their batteries are exhausted and they have to be surgically replaced with a new unit. Typically ICDs deliver biphasic shocks of up to a maximum of 30-45 joules, lower than is needed for effective external defibrillation as the devices are in direct contact with the heart tissue of the patient. Subcutaneous ICDs, differ slightly in that they are not in direct contact with the heart of the patient, and these generally deliver biphasic shocks of 65- 80 joules in order to be efficacious. Even at these lower energy levels there is significant pain caused to the patient if a shock is delivered in error by the device. Most existing devices are designed to last for between 5-10 years before their batteries are depleted and they need to be replaced.

Another, equally common type of defibrillator is the Automated External Defibrillator (AED). Rather than being implanted, the AED is an external device used by a third party to resuscitate a person who has suffered from sudden cardiac arrest. Figure 9 illustrates a conventional AED 800, which includes a base unit 802 and two pads 804. Sometimes paddles with handles are used instead of the pads 804. The pads 804 are connected to the base unit 802 using electrical cables 806.

A typical protocol for using the AED 800 is as follows. Initially, the person who has suffered from sudden cardiac arrest is placed on the floor. Clothing is removed to reveal the person's chest 808. The pads 804 are applied to appropriate locations on the chest 808, as illustrated in Figure 9. The electrical system within the base unit 802 generates a high voltage between the two pads 804, which delivers an electrical shock to the person. Ideally, the shock restores a normal cardiac rhythm. In some cases, multiple shocks are required.

Brief Description of the Drawings

Figure 1 illustrates a medical device having a biphasic or multiphasic waveform generator that delivers a therapeutic pulse to a patient; Figure 2 illustrates a defibrillator medical device with a multiphasic waveform generator with a plurality of independent subsystems each with its own energy reservoir and energy source;

Figure 3 illustrates a defibrillator medical device with a biphasic waveform generator with two independent subsystems each with its own energy reservoir and energy source;

Figure 4 illustrates a standard biphasic pulse waveform where the second (negative) phase of the waveform is smaller in amplitude than that of the first (positive) phase of the waveform;

Figures 5A, 5B and 5C illustrate different examples of a novel biphasic or multiphasic pulse waveform generated by the biphasic or multiphasic waveform generator where the second (negative) phase of the waveform is larger in amplitude than the amplitude of the first (positive) phase of the waveform;

Figure 6 illustrates an embodiment of a biphasic/multiphasic waveform generator with a single circuit containing multiple energy reservoirs which can be dynamically charged separately from a single energy source and then discharged through the H-bridge;

Figure 7 illustrates a biphasic/multiphasic waveform generator with a single circuit containing multiple energy reservoirs which can be dynamically charged separately and then discharged through an H-bridge;

Figure 8 illustrates a circuit for adjusting the biphasic or multiphasic waveform generator system's capacitance;

Figure 9 diagrammatically illustrates an example of a conventional external defibrillator; and

Figure 10 illustrates a circuit for adjusting the waveform generator system's

resistance/impedance.

Detailed Description of One or More Embodiments

The disclosure is applicable to various medical devices including all defibrillator types: external (manual, semi-automated, and fully automated), wearable, implantable and

subcutaneous implantable. In addition to defibrillators, the medical device may also be cardioverters and external/internal pacers, as well as other types of electrical stimulation medical devices, such as: neuro-stimulators, musculo-skeletal stimulators, organ stimulators and nerve/peripheral nerve stimulators, whether the devices are external or implantable. The novel biphasic or multiphasic waveform generator may be particularly useful for any type of defibrillator and examples of the novel biphasic or multiphasic waveform generator system will be described in the context of a defibrillator for illustration purposes. It will be appreciated, however, that the novel biphasic or multiphasic waveform generator may generate and deliver a much wider range of waveforms than has previously been possible in the art (or as shown in the examples) including a new generation/family of novel biphasic or multiphasic waveforms, as shown in Figure 5A, Figure 5B and Figure 5C. Thus, the novel biphasic or multiphasic waveform generator has greater utility to existing devices since it may be used to generate one or more of this family of novel lower energy biphasic pulses. For example, the novel biphasic or multiphasic waveform generator may be configured to generate and deliver a wide range of the new low energy biphasic or multiphasic waveforms with varying pulse timings, phase tilts and amplitudes. Such waveforms can be used in the various medical devices described above. In these devices the pulse generator system may be used to generate therapeutic treatment pulses and then provide the pulses to a patient using paddles or pads or other suitable forms of electrodes.

The novel biphasic or multiphasic waveform generator can be embodied in a number of different ways, constituting a range of different potential circuit designs all of which are within the scope of this disclosure since any of the circuit designs would be able to generate and deliver a wide range of biphasic and/or multiphasic waveforms including the new family/generation of low energy biphasic and/or multiphasic waveforms where the first phase of the waveform has a lower amplitude than the second phase of the waveform.

Figure 1 illustrates a medical device system 100 having a novel biphasic or multiphasic waveform generator 104 that delivers a therapeutic pulse to a patient 112. As described above, the medical device system may be any type of defibrillator system or any of the other types of medical devices described above including cardioverters and external/internal pacers, as well as other types of electrical stimulation medical devices, such as: neuro-stimulators, musculoskeletal stimulators, organ stimulators and nerve/peripheral nerve stimulators, whether the devices are external or implantable. Each of these different types of medical device above may deliver a therapeutic waveform to the patient that has a different therapeutic use including defibrillation, nerve stimulation, neuro stimulation or muscle stimulation. Thus, the biphasic or multiphasic waveform may be used for each of these different therapeutic uses. The medical device system 100 may include a medical device 102 that generates and delivers a novel biphasic or multiphasic pulse waveform 110 to a patient 112. The novel biphasic or multiphasic pulse waveform 110 may be a therapeutic pulse, a defibrillation pulse and the like. As shown in Figure 1, the medical device 102 may include a novel multiphasic or biphasic waveform generator 104, an energy source 106 and a control logic 108. The novel multiphasic or biphasic waveform generator 104 may generate a novel biphasic or multiphasic pulse waveform 110 using the energy stored/generated by the energy source 106.

The novel biphasic or multiphasic pulse waveform 110 may have one or more first phases and one or more second phases wherein the first and second phases may be opposite polarities. In one biphasic waveform example, the first phase may be a positive phase, the second phase may be a negative phase and the second phase of the waveform may be larger in amplitude than the amplitude of the first phase of the waveform as shown in Figures 5 A and 5B. Further, as shown in Figure 5C, a novel multiphasic pulse waveform that may be generated by the multiphasic or biphasic waveform generator 104 is shown in which the biphasic or multiphasic pulse waveform 110 has more than one first phases and more than one second phases of the pulse waveform. In the example in Figure 5C, each first phase has a positive polarity and each second phase has a negative polarity. For example, the amplitude of the second phase may be less than 2500 volts and the first phase would be smaller than the second phase. The multiphasic or biphasic waveform generator 104 may deliver an energy of between 0.1 to 200 joules of energy to a patient during the first phase and second phase of the generated pulse waveform and an inter- pulse period between the first and second phases. The multiphasic or biphasic waveform generator 104 may deliver the therapeutic waveform to the patient during a 2ms to 20ms time period. When the medical device is a nerve stimulator or a neuro stimulator, the therapeutic waveform may be delivered to the patent during a time period that is less than 1 μ second.

The control logic unit 108 may be coupled to and/or electrically connected to the multiphasic or biphasic waveform generator 104 and the energy source 106 to control each of those components to generate various version of the biphasic or multiphasic pulse waveform 110. The energy source 106 may be one or more power sources and one or more energy reservoirs. The control logic unit 108 may be implemented in hardware. For example, the control logic unit 108 may be a plurality of lines of computer code that may be executed by a processor that is part of the medical device. The plurality of lines of computer code may be executed by the processor so that the processor is configured to control the multiphasic or biphasic waveform generator 104 and the energy source 106 to generate the biphasic or multiphasic pulse waveform 110. In another embodiment, the control logic unit 108 may be a programmable logic device, application specific integrated circuit, a state machine, a microcontroller that then controls the multiphasic or biphasic waveform generator 104 and the energy source 106 to generate the biphasic or multiphasic pulse waveform 110. The control logic unit may also include analog or digital switching circuitry when the high voltage switching component 109 is part of the control logic unit 108.

As shown in Figure 1, the biphasic or multiphasic pulse waveform 110 may be delivered to the patient 112 using one or more patient contact devices. The one or more patient contact devices may be, for example, an electrode, a wire, a paddle, a pad or anything else that is capable of delivering the biphasic or multiphasic pulse waveform 110 to the patient 112. To further illustrate a medical device that has the multiphasic or biphasic waveform generator 104 and the energy source 106, an example of a defibrillator that has the multiphasic or biphasic waveform generator 104 and the energy source 106 is now described in further detail.

Figure 2 illustrates a defibrillator medical device 10 with a multiphasic waveform generator with a plurality of independent subsystems each with its own energy reservoir and energy source and Figure 3 illustrates a defibrillator medical device 10 with a biphasic waveform generator with two independent subsystems each with its own energy reservoir and energy source. In an embodiment of the novel multiphasic or biphasic waveform generator 104 and the energy source 106, the components may use two or more physically and electrically distinct subsystems 12, 14 in which each subsystem has the waveform generator 104, the energy source 106 and the control logic 108 as shown in Figures 2-3. The reservoirs of stored electrical energy may be in two or more different circuits (see Figure 2 and Figure 3) that function together in a coordinated fashion in order to generate and deliver the pulse waveform where each phase of the waveform is produced from a separate reservoir of the stored energy. The reservoirs of energy may be of the same size/quantity or else of widely different sizes and may be supplied by one or more energy sources. The energy source 106 is not limited to any particular number of energy reservoirs (such as capacitors) or energy sources (such as batteries). Thus, the medical device system 10 may have a plurality or "n" number (as many as wanted) of subsystems 12, 14 that together can be utilized to generate the various multiphasic or biphasic waveforms. In the example embodiments shown in Figure 2 and Figure 3, there may be two sides, such as side A and side B as shown, and each side may have one or more of the subsystems 12, 14 and each subsystem may generate a phase of the pulse waveform to generate the biphasic or multiphasic waveform with one or more first phases and one or more second phases. The two or more subsystems 12, 14 permit the system to shape the various characteristics of first and second phases separately from each other. For example, in one example, the first phase may have a positive polarity and its characteristics may be shaped independently of the second phase that may have a negative polarity and its characteristics. The above described functions may be accomplished through the use of a fast switching high-energy / voltage switch system as described below. The fast switching high- energy / voltage switch system 109 may be part of the control logic unit 108 or the generator 104.

Each subsystem 12, 14 of each side, as shown in Figure 2 and Figure 3, may have the control logic and heart rhythm sense component 108 (that is connected to a similar component on the other side by a digital control link 30 as shown in Figure 2 and Figure 3) that may be also coupled to a high voltage switching system component 109. The high voltage switching system component 109 may be implemented using either analog circuits or digital circuits or even some hybrid of the two approaches. Furthermore, the high voltage switching system component 109 may be implemented through the use of mechanical or solid-state switches or a combination of the two. The energy reservoir may also be coupled, by a high voltage return line 32 to the other side of the system as shown in Figure 2 and Figure 3. The high voltage return 32 electrically completes the circuit and is present in existing defibrillators, but in a slightly different form since in the existing style of devices it is split into two parts in the form of the two leads which go from the main defibrillator device to the internal or external surface of the patient.

Figures 5A-5C illustrate examples of the biphasic or multiphasic waveforms that may be generated by the systems shown in Figures 2-3 as well as the systems shown in Figures 6-8. In the examples in Figures 5A-5B a first phase may be a positive polarity and the second phase may be a negative polarity. However, the biphasic or multiphasic waveforms also may have a negative polarity first pulse and a positive polarity second pulse. As shown in Figures 5A and 5B, the first phase pulse amplitude may be smaller than the second phase amplitude. Figure 5C illustrates a multiphasic waveform in which the waveform has two or more positive polarity phases and two or more negative polarity phases.

In another embodiment (see Figure 6) the system 10 makes use of two or more reservoirs of stored electrical energy 501 (such as high voltage generator and reservoir 1061, high voltage generator and reservoir 1062 and high voltage generator and reservoir 106n) that are either statically or dynamically allocated from within a single circuit 502 and that function together in a coordinated fashion in order to generate and deliver the final waveform where each phase of the waveform is produced from a separate reservoir of the stored energy. The reservoirs of energy 501 may be of the same size/quantity or else of widely different sizes and may be supplied by one or more energy sources. The system 10 may also have the high voltage switch 109 for each reservoir 501 and an H-bridge switch 110 that may be part of the control logic unit 108 or the generator 104. The H-bridge circuit is a known electronic circuit that enables a voltage to be applied across a load, M, in either direction using one or more switches (see

http://cp.literature.agilent.com/litweb/pdf/5989-6288EN.pdf that is incorporated by reference herein for additional details about the H-bridge circuit.)

In another embodiment (see Figure 7) the system makes use of at least one reservoir of stored electrical energy 601 in a configuration that is divided up and either statically or dynamically allocated into two or more portions of stored energy 602 from within a single circuit and that generates and delivers the final waveform in a coordinated fashion where each phase of the waveform is produced from a separate portion of the stored energy. The portions of energy 602 may be of the same size/quantity or else of widely different sizes and may be supplied by the one or more energy sources. Essentially, this involves charging one or more group(s)/array(s) of capacitors (the number of capacitors in a statically or dynamically created group is based on the voltage and energy requirements for the phase of the waveform or waveform that is to be generated and delivered) and then discharging a select number of capacitors in a group that is configured as required to provide the desired waveform or phase of a waveform. The charging and discharging of capacitors in parallel and in series is well known in the art. Through a configuration of switches (mechanical or solid state) one can disconnect a certain number of capacitors from the original group/array of capacitors, thus separating the stored energy into two (or more) portions/reservoirs that feed an H-bridge switch 110, allowing the creation of a wide range of waveform phases with different amplitudes, shapes and timings.

Another embodiment of the system makes use of a direct current generation source in order to generate the initial phase of the waveform and then uses one or more reservoirs of stored electrical energy in order to generate the second phase of the waveform and any additional phases of the waveform. The energy reservoirs used may be supplied by one or more energy sources.

Another embodiment of the system makes use of a direct current generation source in order to generate the initial phase of the waveform and then uses one or more additional direct current generation sources, configured alone, together, or else in combination with reservoirs of stored electrical energy, in order to generate the second phase of the waveform and any additional phases of the waveform. The energy reservoirs used may be supplied by one or more energy sources.

In additional embodiments, the pulse generator may be configured with the circuitry, processors, programming and other control mechanisms necessary to separately and individually vary the phase timings, the inter-phase pulse timing(s), the phase tilts and the phase amplitudes necessary to customize and optimize the waveform for the patient at hand and for the specific therapeutic purpose for which the waveform is being used.

The above described functions may be accomplished through the use of a fast switching high-energy / voltage switch system 109 which can be either analog or digital in nature or even some hybrid of the two approaches as shown in Figure 2 and Figure 3. The switching can be accomplished through the use of mechanical or solid-state switches or a combination of the two.

Other embodiments of the system discharge part of the waveform's initial phase energy through the use of a statically or dynamically allocated group of resistive power splitters (see Figure 10), which steps the waveform's initial phase amplitude down across the group of resistors, and in this manner delivers a smaller remaining amplitude of the waveform's initial phase to the patient, while still delivering a full amplitude of the second phase (and any additional phases) to the patient.

Many embodiments of the system can make use of one or more additional circuitry modules or subsystems intended to alter the RC constant of the pulse delivery circuitry for one or more of the pulse phases, and hence alter the tilt of the phase of the pulse waveform involved. These modules or subsystems can consist of an array of capacitors or an array of resistors, or of a combination of the two (see Figure 8 and Figure 10).

In some embodiments of the system, the system may provide for the recharging of individual energy reservoirs by the energy sources during times (including inter-phase pulse times) that an individual energy reservoir is not selected for discharge. This provides the opportunity to interlace equivalent amplitude initial multiphasic pulses utilizing several different high energy reservoirs.

While the foregoing has been with reference to a particular embodiment of the disclosure, it will be appreciated by those skilled in the art that changes in this embodiment may be made without departing from the principles and spirit of the disclosure, the scope of which is defined by the appended claims.

Claims

Claims:

1. A medical device, comprising:

an energy source; and

a therapeutic signal generator coupled to the energy source that generates a therapeutic pulse waveform having at least one first phase and at least one second phase of the therapeutic pulse waveform, wherein the first phase of the therapeutic pulse waveform has a smaller amplitude than an amplitude of the second phase of the therapeutic pulse waveform; and

at least two electrodes electrically connected to the therapeutic signal generator through which the therapeutic pulse waveform is delivered to a patient.

2. The device of claim 1, wherein the at least one first phase has a first polarity and the at least one second phase has an opposite polarity.

3. The device of claim 2, wherein the first polarity is a positive polarity and the opposite polarity is a negative polarity.

4. The device of claim 3, wherein the energy source further comprising:

a first subsystem that generates the at least one first phase, the first subsystem having a power source and an energy reservoir,

a second subsystem that generates the at least one second phase, the second subsystem having a second power source and a second energy reservoir; and

a switching component that switches between the first and second subsystems to generate and deliver the therapeutic pulse waveform having at least one positive phase and at least one negative phase.

5. The device of claim 1, wherein the therapeutic pulse waveform delivers between 0.1 joules to 200 joules of energy to the patient during a therapeutic pulse waveform period of between 2ms to 20ms.

6. The device of claim 1, wherein the at least one first phase and the at least one second phase each have a set of characteristics, the set of characteristics comprising a first signal time and a first signal amplitude, a slope time and a slope value and a second signal time and a second signal amplitude and wherein the therapeutic signal generator is capable of adjusting any of the set of characteristics.

7. The device of claim 1, wherein the therapeutic pulse waveform has an inter-phase period between the at least one first phase and at least one second phase and wherein the therapeutic signal generator is capable of adjusting the inter-phase period.

8. The device of claim 1, wherein the energy source further comprises a subsystem that generates the at least one first phase and the at least one second phase, the subsystem having a plurality of power sources and a plurality of energy reservoirs and a control system coupled to the plurality of power sources and the plurality of energy reservoirs, wherein the control system allocates a first group of the power sources and energy reservoirs to generate the at least one first phase and allocates a second group of the power sources and energy reservoirs to generate the at least one second phase.

9. The device of claim 1, wherein the therapeutic pulse waveform is delivered to the patient during a period of less than 2 milliseconds.

10. The device of claim 1, wherein the therapeutic pulse waveform is delivered to the patient during a period of less than 1 microsecond.

11. The device of claim 1, wherein the therapeutic pulse waveform is a biphasic signal having one first phase and one second phase.

12. The device of claim 1, wherein the therapeutic pulse waveform is a multiphasic signal having a plurality of first phases and a plurality of second phases, wherein a first one of the first phase has a smaller amplitude than the plurality of second phases.

13. The device of claim 1, wherein the therapeutic pulse waveform stimulates a nerve of the patient.

14. The device of claim 1, wherein the therapeutic pulse waveform stimulates a muscle of the patient.

15. The device of claim 1, wherein the therapeutic pulse waveform provides neurological stimulation.

16. The device of claim 1, wherein the therapeutic pulse waveform provides defibrillation.

17. The device of claim 1, wherein the device is one of a wearable defibrillator, an implantable defibrillator and an external defibrillator.

18. The device of claim 1, wherein the therapeutic pulse waveform provides cardioversion.

19. The device of claim 1, wherein the therapeutic pulse waveform provides pacing.

20. The device of claim 1, wherein the therapeutic pulse waveform stimulates an organ of the patient.

21. A method for delivering a therapeutic signal, comprising:

providing an energy source and a therapeutic signal generator coupled to the energy source;

generating, using the energy source and the therapeutic signal generator, a therapeutic pulse waveform having at least one first phase and at least one second phase of the therapeutic pulse waveform, wherein the first phase of the therapeutic pulse waveform has a smaller amplitude than an amplitude of the second phase of the therapeutic pulse waveform; and

delivering the generated therapeutic pulse waveform to the patient.

22. The method of claim 21 , wherein the at least one first phase has a first polarity and the at least one second phase has an opposite polarity.

23. The method of claim 22, wherein the first polarity is a positive polarity and the opposite polarity is a negative polarity.

24. The method of claim 23, wherein generating the therapeutic pulse waveform further comprises:

generating, using a first subsystem having a power source and an energy reservoir, the at least one first phase;

generating, using a second subsystem having a second power source and a second energy reservoir, the at least one second phase; and

switching, using a switching component, between the first and second subsystems to generate and deliver the therapeutic pulse waveform having at least one positive phase and at least one negative phase.

25. The method of claim 21, wherein delivering the generated therapeutic pulse waveform further comprising delivering the therapeutic pulse waveform between 0.1 joules to 200 joules of energy to the patient during a therapeutic pulse waveform period of between 2ms to 20ms.

26. The method of claim 21, wherein the at least one first phase and the at least one second phase each have a set of characteristics, the set of characteristics comprising a first signal time and a first signal amplitude, a slope time and a slope value and a second signal time and a second signal amplitude and further comprising adjusting, by the therapeutic signal generator, any of the set of characteristics.

27. The method of claim 21, wherein the therapeutic pulse waveform has an interphase period between the at least one first phase and at least one second phase and further comprising adjusting, by the therapeutic signal generator, the inter-phase period.

28. The method of claim 21, wherein generating the therapeutic pulse waveform further comprises:

providing a subsystem that generates the at least one first phase and the at least one second phase, the subsystem having a plurality of power sources and a plurality of energy reservoirs;

allocating, by a control system that is coupled to the plurality of power sources and the plurality of energy reservoirs, a first group of the power sources and energy reservoirs to generate the at least one first phase; and

allocating, by the control system, a second group of the power sources and energy reservoirs to generate the at least one second phase.

29. The method of claim 21, wherein the therapeutic pulse waveform is delivered to the patient during a period of less than 2 milliseconds.

30. The method of claim 21, wherein the therapeutic pulse waveform is delivered to the patient during a period of less than 1 microsecond.

31. The method of claim 21 , wherein the therapeutic pulse waveform is a biphasic signal having one first phase and one second phase.

32. The method of claim 21 , wherein the therapeutic pulse waveform is a multiphasic signal having a plurality of first phases and a plurality of second phases, wherein a first one of the first phase has a smaller amplitude than the plurality of second phases.

33. The method of claim 21, wherein delivering the generated therapeutic pulse waveform to the patient further comprising delivering the therapeutic pulse waveform to the patient to stimulate a nerve of the patient.

34. The method of claim 21, wherein delivering the generated therapeutic pulse waveform to the patient further comprises delivering the therapeutic pulse waveform to the patient to stimulate a muscle of the patient.

35. The method of claim 21, wherein delivering the therapeutic pulse waveform to the patient to stimulate further comprises providing neurological stimulation.

36. The method of claim 21, wherein delivering the therapeutic pulse waveform to the patient to stimulate further comprises providing defibrillation.

37. The method of claim 21, wherein delivering the therapeutic pulse waveform to the patient to stimulate further comprises providing cardioversion.

38. The method of claim 21, wherein delivering the therapeutic pulse waveform to the patient to stimulate further comprises providing pacing.

39. The method of claim 21, wherein delivering the therapeutic pulse waveform to the patient to stimulate further comprises stimulating an organ of the patient.